Market Research Logo
Region: Africa
Category: Pharmaceuticals

Africa Pharmaceuticals

(303 reports matching your criteria)
  • Uganda Pharmaceuticals & Healthcare Q1 2018

    ... with opportunities being presented for multinationals selling high-value patented drugs. On the other hand, Uganda's public healthcare sector will remain underfunded, and hence underdeveloped, with the private sector remaining the largest in terms of value. Read More

  • Tunisia Pharmaceuticals & Healthcare Q1 2018

    ... sector any beyond, with Tunisia already boasting impressive levels of medical tourism. The next key step will be the removal of market access barriers for innovative medicines, with an uncertain and inflexible regulatory environment currently ... Read More

  • Consumer Health in Ethiopia

    ... offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 ... Read More

  • Consumer Health in Côte d'Ivoire

    ... Côte d'Ivoire report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. ... Read More

  • Ethiopia Pharmaceuticals & Healthcare Q1 2018

    ... limited drugmaker opportunities. Reflective of the low purchasing power among the population, the majority of drugs in circulation are generic versions, though the presence of multinationals suggests a growing markets for patented medicines in the ... Read More

  • Nigeria Pharmaceuticals & Healthcare Q1 2018

    ... local medicine demand. We expect that domestic drugmakers' performance will improve in line with increasing government support, although the benefits are unlikely to be realised over the near-term. The majority of multinational drugmakers will continue ... Read More

  • Namibia Pharmaceuticals & Healthcare Q1 2018

    ... on a regional comparison, Namibia's pharmaceutical market is small and per capita spending on medicines is below Southern Africa averages, lowering the country's competitiveness. Lingering structural issues in its domestic landscape will also act as ... Read More

  • Botswana Pharmaceuticals & Healthcare Q1 2018

    ... within the public healthcare sector. Furthermore, the country'srelatively business-friendly operating environment and political stability, compared to its regional peers,make it a comparatively attractive destination for multinational investment. However, pharmaceuticalspending is low overall, which will limit ... Read More

  • Herbal/Traditional Products in Nigeria

    ... particularly herbal/traditional dietary supplements. Even products such as herbal/traditional topical analgesics that utilise store retailing are generally sold in traffic in key cities, similar to how a wide variety of less regulated herbal products are ... Read More

  • Cameroon Pharmaceuticals & Healthcare Q1 2018

    ... significant underlying burden of infectious diseases, the burden of non-communicable diseases will continue to increase at a faster rate due to the growing middle class and resulting lifestyle changes, providing improved revenue-earning opportunities for drugmakers ... Read More

  • Morocco Pharmaceuticals & Healthcare Q1 2018

    ... disease treatments. The government's commitment to improving healthcare via the expansion of health insurance coverage will be a significant factor for future medicine sales growth; however, generics drugmakers will be the main beneficiaries as the ... Read More

  • Ghana Pharmaceuticals & Healthcare Q1 2018

    ... Ghanaian government. This also makes up part of Ghana's ongoing economic diversification efforts, parallel to investment into infrastructure, mining and industrial development. Despite a stable economic and political outlook, weak regulatory procedures and operational risks ... Read More

  • Mozambique Pharmaceuticals & Healthcare Q1 2018

    ... has the potential to give rise to strong medicine sales growth, the lack of affordability among the population will mean growth will mainly be in the generic drug segment. High levels of corruption and an ... Read More

  • Algeria Pharmaceuticals & Healthcare Q1 2018

    ... forecast period, driven by rising demand for healthcare and a growing prevalence of chronic diseases. Incentives for pharmaceutical investment will continue to boost local manufacturing capacity. Meanwhile, upside risks are mounting towards drug pricing reform, ... Read More

  • Mauritius Pharmaceuticals & Healthcare Q1 2018

    ... drugmakers over the next ten years. Maurit ius's increasing integration with larger African markets will benefit the island nation health industries while expanding export markets for drug manufacturers over the long term. Mauritius's strategic position ... Read More

  • Angola Pharmaceuticals & Healthcare Q1 2018

    ... such as these will have important implications for public healthcare provision and the long-term potential of Angola's pharmaceutical market. However, opportunities for drugmakers will remain weak, with the country expected to see little improvement regarding ... Read More

  • Sudan and South Sudan Pharmaceuticals & Healthcare Q1 2018

    ... market. While the removal of restrictions will improve Sudan's economic growth outlook and relations with the US, the operating environment remains highly challenging and will continue to restrict company activity from foreign drugmakers. Over the ... Read More

  • Egypt Pharmaceuticals & Healthcare Report Q1 2018

    ... the market's trajectory include the country's growing demand for prescription medicines, a rapid increase in the country's population and growing health awareness. Disputes over medicine pricing, the impact of high inflation and the lasting negative ... Read More

  • South Africa Pharmaceuticals & Healthcare Report Q1 2018

    ... looking to develop a foothold in the wider region. Given the size of the market, it is vital that companies appreciate the varying levels of both investment risk and reward that are present at the ... Read More

  • Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia

    ... and keeps the category interesting. Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia report offers a comprehensive guide to the size and shape of the market at a national level. It provides ... Read More

  • Dermatologicals in Tunisia

    ... products, and this creates opportunities for players in dermatologicals. Euromonitor International's Dermatologicals in Tunisia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest ... Read More

  • NRT Smoking Cessation Aids in Tunisia

    ... provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change. Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT ... Read More

  • Sleep Aids in Tunisia

    ... sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change. Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution ... Read More

  • Herbal/Traditional Products in Tunisia

    ... and push up value sales. The natural living trend is expected to intensify over the forecast period and benefit herbal/traditional products. Tunisian consumers are increasingly focused on health and becoming more likely to research natural ... Read More

  • Analgesics in Tunisia

    ... such ailments is likely to remain extended in order for medication to be covered by health insurance, patients affected by chronic pain are expected to continue to seek other treatments – including, in particular, analgesics ... Read More

< prev 1 3 4 5 6 7 8 9 10